MSB 7.69% $1.19 mesoblast limited

Cell Therapy News/Articles, page-13967

  1. 15,454 Posts.
    lightbulb Created with Sketch. 5535
    this could potentially make MSCs themselves obsolete.

    But what about all the trials they will need to do in the interim before they are approved Doc? Unless of course they get the anonymous posters on HC to set up the trial protocols they could be a decade away from approval so MSC’s will probably do just fine for the time being - just sayin’
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.